Skip to main content

Pharmala Biotech Holdings Inc.(MDMA-CN)
CSE

Today's Change
Delayed Last Update

Stocks in play: Pharmala Biotech Holdings Inc

Baystreet - Fri Aug 5, 2022

Announces it has signed on to act as exclusive supplier of both GMP LaNeo™ MDMA and Engineering MDMA to InterVivo Solutions, its client companies and Affiliates. InterVivo Solutions is a well-established pre-clinical contract research organization with expertise in neuropsychiatric and neurological diseases. Together with Transpharmation, they form the largest boutique neuroscience-specialized in vivo CRO. Pharmala Biotech Holdings Inc shares C.MDMA are trading unchanged at $0.04.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe